Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203333 · ClinicalTrials.gov registry record
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 19
- Enrollment target
NCT00203333 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 19 participants.
The verdict
NCT00203333 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with refractory epilepsy. Several lines of evidence support a cardiac mechanism for SUDEP. This study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in this population and 2. whether these are increased above the general population in the same age group. Additionally, these data will be correlated to specific clinical data, including seizure history, anticonvulsant medications, and any accompanying clinical symptoms.
Interventions
- DEVICE Medtronic REVEAL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2002-04 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203333
The ClinicalTrials.gov registry entry for NCT00203333 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic REVEAL is the first listed.
NCT00203333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00203333 about?
NCT00203333 is a clinical study titled "Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death". People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with...
What is the current status of trial NCT00203333?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2002-04. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00203333?
The interventions under investigation include: Medtronic REVEAL (DEVICE).
Who is sponsoring clinical trial NCT00203333?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.